← Back to Search

Online Support for Safe Infant Care Practices (SUPERSONIC Trial)

N/A
Recruiting
Led By Rachel Y Moon, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between 2 and 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to help more parents follow safe sleep guidelines and breastfeed their babies for longer by using private Facebook groups to provide education and support from peers. The goal is to reduce differences in these practices

Who is the study for?
This trial is for pregnant individuals in the U.S. who are less than 30 weeks along, enrolled or enrolling at a WIC center, speak English, and have daily access to Facebook and SMS texting.
What is being tested?
The study tests if private Facebook groups providing multimedia education on safe sleep practices and breastfeeding can improve adherence to these practices and reduce racial disparities.
What are the potential side effects?
There are no direct medical side effects from participating in this trial as it involves educational interventions through social media rather than medical treatments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between 2 and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and between 2 and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Breastmilk feeding in the previous two weeks
Infant sleep location in the previous two weeks
Infant sleep position in the previous two weeks
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Safe Sleep and BreastfeedingExperimental Treatment2 Interventions
Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for infant safe sleep and breastfeeding, and b) an online community and social network of other pregnant WIC clients and new parents
Group II: Safe SleepExperimental Treatment1 Intervention
Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for infant safe sleep and b) an online community and social network of other pregnant WIC clients and new parents
Group III: BreastfeedingExperimental Treatment1 Intervention
Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for breastfeeding and b) an online community and social network of other pregnant WIC clients and new parents
Group IV: Early Brain Development and Parent -Child RelationshipsActive Control1 Intervention
Participants will be part of a private Facebook group from approximately 32 weeks gestation to 6 months postpartum. The Facebook group will provide a) evidence-based education through videos and other multi-media supporting best practices for early brain development and parent-child interactions (control intervention) and b) an online community and social network of other pregnant WIC clients and new parents.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Breastfeeding
2007
Completed Phase 3
~2660

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
782 Previous Clinical Trials
1,312,702 Total Patients Enrolled
Boston UniversityOTHER
473 Previous Clinical Trials
9,987,833 Total Patients Enrolled
Washington University School of MedicineOTHER
1,993 Previous Clinical Trials
2,293,082 Total Patients Enrolled
~1154 spots leftby May 2025